The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses...

The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines

Rødland, Gro Elise, Melhus, Katrine, Generalov, Roman, Gilani, Sania, Bertoni, Francesco, Dahle, Jostein, Syljuåsen, Randi G., Patzke, Sebastian
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Journal:
Frontiers in Oncology
DOI:
10.3389/fonc.2019.01301
Date:
November, 2019
File:
PDF, 2.29 MB
2019
Conversion to is in progress
Conversion to is failed